(1 - 30 von 54
)
NEWS - NEUVOGENneuvogen.com › news
neuvogen.com
January 25, – NEUVOGEN Appoints Dr. Christian Ottensmeier Head of Scientific Advisory Board. January 20, – NEUVOGEN Announces Participation at ...
Cancer researchers in Southampton are set to share in a £15m cash...
www.dailyecho.co.uk
CANCER researchers in Southampton are set for a £15m cash boost.
Cancer breakthrough close as scientists begin testing wonder drug AMG...
www.express.co.uk
A WONDER drug that teaches the immune system to kill cancer could provide a breakthrough in the fight against the disease, say scientists.
Scientists find new biomarker to guide cancer immunotherapy | Reuters
www.reuters.com
Scientists said on Monday they had pinpointed a particular type of immune system cell that could predict more precisely if cancer patients are likely to...
Guardian: The new cancer trial that offers hope to thousands | Society | The...
Across the country 800 terminally ill men and women have agreed to be human guinea pigs in a hunt for new cancer drugs
Antibody-drug conjugates on the up in cancer - PMLiVE
www.pmlive.com
... in recent years, according to Professor Christian Ottensmeier, professor experimental medicine at the University of Southampton in the UK.
Ladenlokal an der Bahnhofstraße und Verlegung der ...www.westfalen-blatt.de › OWL › Kreis Gütersloh
www.westfalen-blatt.de
Zum zweiten kündigt Christian Ottensmeier die Verlegung seiner Werkstatt an den Langen Brink an, wo 300 Quadratmeter im Höpfner-Komplex ...
Lung cancer treatment - immunotherapy breakthrough could ...www.express.co.uk › ... › Health
www.express.co.uk
Professor Christian Ottensmeier, Cancer Research UK scientist at the University of Southampton, said: “These are hugely exciting results.
Scientists find new biomarker to guide cancer immunotherapywww.reuters.com › article
www.reuters.com
· “Having made the first baby steps with PDL-1 testing, we need to be smarter by using new tests,” said Christian Ottensmeier, a Cancer ...
OncoSec Appoints Scientific Advisory Board
www.finanznachrichten.de
Christian Ottensmeier is Professor in Experimental Cancer Medicine. Following a 3 year training fellowship at the Dana Farber Cancer Institute ...
OncoSec Medical to Initiate Multiple Phase II Skin Cancer Clinical...
www.finanznachrichten.de
26 May CHRISTIAN OTTENSMEIER, M.D., is one of the UK''s leading ...
First Human Demonstration of Significant, Persistent Antibody...
www.finanznachrichten.de
Inovio Biomedical & University of Southampton Collaborative Clinical Study Establishes Important Humoral Immune Response of Prostate Cancer DNA Vaccine Using...
Cancer Research UK, University of Southampton and Touchlight Genetics...
www.touchlight.com
Professor Christian Ottensmeier, Chief Clinical Investigator at the University of Southampton, said: “We hope this new DNA cancer vaccine will ...
CTRad and Combinations Alliance Radiotherapy-Immunotherapy Workshop,...
www.ecmcnetwork.org.uk
Professor Martin Glennie went on to discuss immuno-regulatory agents and Professor Christian Ottensmeier (Southampton ECMC) described the translational ...
Discovery of New Immune Cell May Improve Treatment of Lung Cancer...
www.genengnews.com
New type of immune cell discovery may help predict which lung cancer patients will benefit most from immunotherapy.
Cancer immunotherapy update and Sylvia Lawler Prize
www.rsm.ac.uk
This is an update on the latest developments of immunotherapy for treating lung cancer.
Discovery could guide immunotherapy for lung cancerwww.manufacturingchemist.com › article_page › Di...
www.manufacturingchemist.com
· Professor Christian Ottensmeier, Cancer Research UK scientist at the University of Southampton, said: “These are hugely exciting results.
Scientists discover new type of immune cell - PharmaTimes
www.pharmatimes.com
Scientists from the UK and US say they have identified a new type of immune cell that could be able to predict which lung cancer patients will benefit most...
Leukemia: Positive Early Results For WT1 DNA Vaccine Clinical Trial...
www.science20.com
The early results of a trial to treat leukemia with a WT1 DNA vaccine looks promising, according to a presentation at the DNA Vaccines conference in...
History of Changes for Study: NCT
clinicaltrials.gov
Contact:Contact: West Belgium ... Contact:Contact: Christian Ottensmeier uk.
History of Changes for Study: NCT ClinicalTrials.govclinicaltrials.gov › history › NCT
clinicaltrials.gov
Contact: West Belgium ... [Recruiting] Halle, Germany ... Contact: Christian Ottensmeier [Recruiting]
Tumor immune fitness determines survival of lung cancer patients | La...
www.lji.org
La Jolla Institute for Immunology. We have relied on the strength of our people and the quality of our research.
The Future of Medicine - Cancer Immunology | Pint of Science
pintofscience.co.uk
For many years, most cancer treatment has focused around the use of chemotherapy and radiotherapy with varying sucess rates. However there is now a 'new ki...
Speakers | BACR - The British Association for Cancer Researchwww.bacr.org.uk › event › speakers
www.bacr.org.uk
Prof Christian Ottensmeier University of Liverpool. BACR is a registered charity in England and Wales ( ) Registered address:
Researchers study potential vaccine to prevent head and neck cancer |...
www.southampton.ac.uk
Researchers in Southampton and Malaysia are set to launch a pioneering study that could lead to the development of a vaccine to prevent head and neck cancer.
The 16th International Conference on Progress in Vaccination Against...
www.rsc.org
Committee. Christian Ottensmeier United Kingdom. http://www.southampton.ac.uk/medicine/about/staff/cho.page. Robert C Rees United Kingdom.
Scancell establishes clinical advisory board
www.manufacturingchemist.com
... and the University of Sheffield; Professor Christian Ottensmeier, Professor of Experimental Cancer Medicine at the University of Southampton ...
sortiert nach Relevanz / Datum